Multi-kinase inhibitor 4
Compound 14 is a potent, orally bioavailable multi-kinase inhibitor targeting VEGFRs (FLT1/KDR/FLT4), FLT3, and PDGFRs with low nanomolar IC50 values. It is a valuable research tool for investigating angiogenesis and oncogenesis in both cellular assays and in vivo cancer models.
Product Specifications
CAS Number
2648279-77-8
Field of Research
Cardiovascular Research, Pharmacology & Drug Discovery, Signal Transduction
Smiles
O=C (NC=1ON=C (C1) C (C) (C) C) CC2=CC=C (C=C2) N3C=NC=4C=C (C=CC43) C=5C=NNC5
Molecular Formula
C25H24N6O2
Molecular Weight
440.50
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E-CL-H0845-01 24 Tests
Human S100A13 (S100 Calcium Binding Protein A13) CLIA Kit
Sign In for Pricing
View Details E-CL-H0845-02 48 Tests
Human S100A13 (S100 Calcium Binding Protein A13) CLIA Kit
Sign In for Pricing
View Details E-CL-H0845-03 96 Tests
Human S100A13 (S100 Calcium Binding Protein A13) CLIA Kit
Sign In for Pricing
View Details 
BNC940784-500 1x 500 µL
CD56 / NCAM (NCAM1/784), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
